QBJ

Integrated Continuous Glucose Monitoring System, Factory Calibrated

产品代码
QBJ
器械名称
Integrated Continuous Glucose Monitoring System, Factory Calibrated
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 862.1355
FDA 专业组
Clinical Chemistry
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
7 件
其中 Summary 已存档
6 份,可直接下载
FDA 历史累计 510(k)
18 件(全部年份;本站只收录近三年的明细)

FDA 分类定义

An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with these digitally connected medical devices for the purpose of managing a disease or condition related to glycemic control.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

该代码近三年的 510(k)(7 件)

数据窗口为最近三年。最新一件:2026-06-08。

510(k) 号批准日期申请人器械名称摘要
K2614022026-06-08Dexcom, Inc.Dexcom G7 Continuous Glucose Monitoring System;DexcoPDF
K2537372026-02-03Dexcom, Inc.Dexcom G7 Continuous Glucose Monitoring (CGM) SystemPDF
K2537102025-12-17Dexcom, Inc.Dexcom G7 Continuous Glucose Monitoring (CGM) SystemPDF
K2432142025-04-09Dexcom, Inc.Dexcom G7 15 Day Continuous Glucose Monitoring SystePDF
K2409022024-04-23Dexcom, Inc.Dexcom G7 Continuous Glucose Monitoring SystemPDF
K2335372024-04-23Abbott Diabetes Care, Inc.FreeStyle Libre 3 Continuous Glucose Monitoring SystFDA
K2341332024-02-26Dexcom, Inc.Dexcom G7 Continuous Glucose Monitoring SystemPDF

其中 6 件的 Summary 已存档在本站,点 PDF 直接下载;其余给 FDA 官方链接。

FDA 官方分类页: QBJ
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。